ANGIODYNAMICS INC — Director's Dealing 2011

Oct 20, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2011-10-18

Reporting Person: PANZER ALAN (SVP, GM - Vascular)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-18	Common Stock	A	20000	—	Acquired	20000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-10-18	Non-Qualified Stock Option (right to buy)	$15.50	A	100000	Acquired	2018-10-18	Common Stock (100000)	Direct

Footnotes

F1: The acquisition of 20,000 shares of common stock represents 20,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning on 10/18/2012.

F2: Options for 25% of the shares are each exercisable on 10/18/2012, 10/18/2013, 10/18/2014 and 10/18/2015, respectively.